CMR Surgical and LifeHealthcare are teaming up to bring the Versius robotic keyhole...
- CMR Surgical and LifeHealthcare bring Versius robotic surgery to Australia
- Parkinson’s disease: serotonin link discovery could lead to new screening tools
- New assay allows faster testing of antimalarial drug resistance
- Carers Week 2019: how VR is helping carers empathise with their patients
- Dilemmas in regulating brain-computer interface devices
C4XD collaborates with PhoreMost on Parkinson’s Disease drugs
C4X Discovery (C4XD) has partnered with UK-based biopharmaceutical company PhoreMost to accelerate the Parkinson’s Disease drug discovery pipeline.
Transplant reports positive results in kidney device trial
Transplant Biomedicals has reported positive interim results of the first-in-human clinical trial of the Vivian device in kidney transplantation.
CMR Surgical and LifeHealthcare bring Versius robotic surgery to Australia
CMR Surgical and LifeHealthcare are teaming up to bring the Versius robotic keyhole surgery system to Australia and New Zealand.
CDT licenses Klue’s behavioural software for diabetes treatment
University of Virginia’s (UVA) Center for Diabetes Technology (CDT) has licensed Klue's gesture sensing and behavioural analytics software for a proposed clinical trial to further diabetes treatment.
Parkinson’s disease: serotonin link discovery could lead to new screening tools
Changes to the serotonin system of the brain could act as a crucial early warning signal for Parkinson’s disease and may lead to the development of new screening tools for the chronic condition.
UHN and SQI Diagnostics test new lung transplant technology
University Health Network (UHN) and its partner SQI Diagnostics have tested a new technology to help surgeons evaluate lung health at the time of transplant.
Biotronik’s Orsiro stent may threaten Abbott’s position in US drug-eluting stent market
GlobalData estimates that approximately 95% of all percutaneous coronary interventional (PCI) stenting procedures in the US use a drug-eluting stent (DES).
Medtronic’s new generation stent retriever strengthens its position in US stent market
In the US, stent retrievers are used in approximately 60% of all thrombectomy procedures, according to GlobalData.
FDA approves Cochlear Nucleus Profile Plus Series implant
The US Food and Drug Administration (FDA) has approved the new Cochlear Nucleus Profile Plus Series Cochlear Implant and the Nucleus 7 Sound Processor’s new built-in connectivity which features direct streaming with compatible Android smartphones.
Abbott launches rapid, point-of-care diabetes diagnosis test
Abbott has announced the availability of its Afinion HbA1c Dx assay for use on the Afinion 2 Analyzer and the Afinion AS100 Analyzer in the diagnosis of diabetes.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.
Rolf Rihs has been working at assembly system manufacturer Mikron Automation for nearly 17 years. Over that time, he has…